Compare Becton Dickinson and Co (BDX) vs Incyte Corporation (INCY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Incyte Corporation — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Incyte Corporation trades at $120.45 (market cap $24.54B). The key difference: Becton Dickinson and Co is far larger — about 2× Incyte Corporation's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| BDX | INCY | |
|---|---|---|
Market Cap | $49.41B | $24.54B |
Sector | Health | Health |
52-Week High | $185.39 | $129.93 |
52-Week Low | $138.62 | $81.61 |
Enterprise Value | $65.51B | $20.04B |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →
